Blaise Coleman insider trades

Open-market stock purchases and sales by Blaise Coleman, Director at Ocugen, Inc, from SEC Form 4 filings since Jan 28, 2017.

Recent trades

DateStockTradeValue
Jun 11, 2026OCGN Ocugen, IncBought (not open market)—

Companies traded

  • OCGN Ocugen, Inc: other filings, last Jun 11, 2026
  • ENDP Endo International plc: 1 buy, last Mar 30, 2022

Get free alerts when Blaise Coleman files a new trade →